AcaHealth Pharma & Biotech Co.,LTD

長安醫藥生技 Innovative R&D




Unique in human experienced anti-aging herb

derived drug discovery:

Aim for aging related unmet medical need


AcaHealth Pharma & Biotech Company was founded by Professor & Director Rong-Tsun Wu in2009, originated from Research Center fot Drug Discovery, National Yang-Ming University. Our comany focus on:

1. Pure chemical drug discovery development.

AcaHealth company focus on human experienced medicine-based drug discovery & development, aiming for unmet medical need especially aging related diseases such as chronic heart failure, chronic kidney disease, dry eye, neurodegenerative diseases, macular degeneration or insomnia.

AcaHealth Company granted US FDA & Taiwan FDA IND for EH-201 clinical trial (AH-101-CVD,Chronic Heart Failure) in 2020. We completed phase Ia 6 cohorts single doses clinical trial in Taipei Medical University Hospital in 2021 Dec. DSMB is OK.


2. EH-201 & Its derivatives chemical synthesis.

3. Apply the IND for dry eye, Chemotherapy induced anemia and chronic kidney disease.


Copyright © 2020 長安醫藥生技 AcaHealth Pharma & Biotech Company

WebMake SiteBuild | HiYP B2B Service | TaiwanDNS